Canada
· Delayed Price · Currency is CAD Oncolytics Biotech Statistics
Total Valuation
TSX:ONC has a market cap or net worth of CAD 43.97 million. The enterprise value is 29.66 million.
| Market Cap | 43.97M |
| Enterprise Value | 29.66M |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:ONC has 88.82 million shares outstanding. The number of shares has increased by 11.26% in one year.
| Current Share Class | 88.82M |
| Shares Outstanding | 88.82M |
| Shares Change (YoY) | +11.26% |
| Shares Change (QoQ) | +9.10% |
| Owned by Insiders (%) | 3.44% |
| Owned by Institutions (%) | 1.54% |
| Float | 85.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.77 |
| P/TBV Ratio | 6.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.94 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.13 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.21 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.04 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -213.85% and return on invested capital (ROIC) is -131.59%.
| Return on Equity (ROE) | -213.85% |
| Return on Assets (ROA) | -76.34% |
| Return on Invested Capital (ROIC) | -131.59% |
| Return on Capital Employed (ROCE) | -238.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.13M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.78% in the last 52 weeks. The beta is 1.51, so TSX:ONC's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -66.78% |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 26.44 |
| Average Volume (20 Days) | 123,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.26M |
| Pretax Income | -31.37M |
| Net Income | -31.50M |
| EBITDA | -33.16M |
| EBIT | -33.26M |
| Earnings Per Share (EPS) | -0.40 |
Balance Sheet
The company has 15.30 million in cash and 1.00 million in debt, giving a net cash position of 14.30 million or 0.16 per share.
| Cash & Cash Equivalents | 15.30M |
| Total Debt | 1.00M |
| Net Cash | 14.30M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 6.49M |
| Book Value Per Share | 0.08 |
| Working Capital | 12.72M |
Cash Flow
In the last 12 months, operating cash flow was -26.00 million and capital expenditures -193,000, giving a free cash flow of -26.19 million.
| Operating Cash Flow | -26.00M |
| Capital Expenditures | -193,000 |
| Free Cash Flow | -26.19M |
| FCF Per Share | -0.29 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:ONC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.26% |
| Shareholder Yield | n/a |
| Earnings Yield | -71.65% |
| FCF Yield | -59.56% |
Stock Splits
The last stock split was on May 25, 2018. It was a reverse split with a ratio of 0.105263.
| Last Split Date | May 25, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.105263 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |